Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate (Q40678731)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 1995
edit
Language Label Description Also known as
English
Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate
scientific article published on November 1995

    Statements

    Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate (English)
    Moreland LW
    Pratt PW
    Mayes MD
    Postlethwaite A
    Weisman MH
    Schnitzer T
    Lightfoot R
    Calabrese L
    Zelinger DJ
    Woody JN
    1 November 1995
    11
    1581-1588

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit